The Danish pharmaceutical company has struggled in recent months to meet its lofty sales expectations.
The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity medications.
In early animal tests, the experimental TDN triggered weight loss without nausea or vomiting.
People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to discontinue use.
New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone levels.
Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?
People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.
People taking Amgen's MariTide lost up to 20% of their body weight in a Phase II trial.
Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug on the market.
Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.
The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent mandate. Hims pushed back against the accusation.
Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.
By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body mass while still trimming pounds.
Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
New research finds that ER visits related to semaglutide use might be on the rise.
A recent survey reveals the foods that people are less likely to eat once they start taking GLP-1 medications like Ozempic.
Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose weight—without the nauseating symptoms now commonly seen with GLP-1 drugs.
Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.
A new study is the latest to find no evidence that GLP-1 drugs like Ozempic increase the risk of suicide.
